-
Clinical Trials & Development1 month agoBoehringer launches hub for patient experience data
Boehringer Ingelheim has launched a hub to help patient organisations gather and use patient experience data (PED) more effectively.
-
Clinical Trials & Development1 month agoLongeveron’s phase 2b stem cell flop spurs cost cutting, exploration of ‘all options’
A phase 2b study of Longeveron’s stem cell therapy in a pediatric heart disease has missed its primary endpoint, prompting the cash-strapped biotech to “review all...
-
Clinical Trials & Development1 month agoC3TI Compass (Knowledge Repository)
Centralized knowledge repository for clinical trial innovation
-
Clinical Trials & Development1 month ago
Vera’s strong phase 3 IgAN data for Trutakna intensify kidney disease rivalry
New phase 3 data show Vera Therapeutics’ Trutakna successfully stabilizes kidney function in IgA nephropathy patients, mirroring an earlier clinical success from Otsuka’s Voyxact and heating...
-
Clinical Trials & Development1 month ago‘Patients are not a renewable resource’: Rethinking rare disease R&D
Small patient communities face repeated demands for samples, data and time. The Speak Foundation’s founder explains how pharma can ease that burden while strengthening patients’ R&D...
-
Clinical Trials & Development1 month agoWhere female participation in clinical trials has caught up — and where gaps remain
Getting more women into drug R&D remains critical for boosting health outcomes. But in some disease areas, pharma is still falling behind.
-
Clinical Trials & Development1 month agoNovartis halts TREM2 targeting ALS program in 4th trial stumble in a month
The TREM2 stabilizer failed to show efficacy in a Phase 2 trial of patients with early-stage ALS. This development follows two late-stage trial failures reported by...
-
Clinical Trials & Development1 month ago
Novartis ends ALS program after phase 2 flop, adding to R&D woes
Novartis has extended its losing streak, stopping an amyotrophic lateral sclerosis program after flunking a phase 2 trial.
-
Clinical Trials & Development1 month agoDrug Safety Communications
FDA Drug Safety Communications connect consumers and health care professionals to important drug safety information.
-
Clinical Trials & Development1 month ago
Sling reels in $123M series C to fund oral Tepezza rival through phase 3 trial
Sling Therapeutics has closed a $123 million series C round to advance its oral therapy for thyroid eye disease through a phase 3 trial and hopefully...
Genmab’s cancer bispecific delivers early survival win in ‘exceedingly positive’ Phase 3 readout
Genmab’s cancer bispecific delivers early OS win in ‘exceedingly positive’ Phase 3 readout
STAT+: HHS moves to allow compounding of some unapproved peptides
Novartis buys Synnovation’s PI3Kα inhibitors for $3 billion
Novartis to pay $2B upfront to take next-gen PI3Kα inhibitor from Synnovation
